# Continuous Femoral Nerve Blockade and Readiness to Discharge Following Total Knee Arthroplasty

> **NCT00803348** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 99 (actual)

## Conditions studied

- Knee Arthroplasty

## Interventions

- **DRUG:** Bolus of 0.2% ropivicaine 20 mls followed by 0.2% ropivicaine at an infusion rate of 5mls/hr until 0600 on postoperative day 2
- **DRUG:** Bolus of 0.2% ropivicaine 20 mls followed by 0.1% ropivicaine at an infusion rate of 10mls/hr until 0600 on post-operative day 2
- **DRUG:** Saline control

## Key facts

- **NCT ID:** NCT00803348
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2012-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00803348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00803348, "Continuous Femoral Nerve Blockade and Readiness to Discharge Following Total Knee Arthroplasty". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00803348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*